MA
AHPI

MYDA Advisors’s Allied Healthcare Products AHPI Stock Holding History

MYDA Advisors’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20,000
Closed -$350K – 183
2020
Q1 		$350K Buy
+20,000
New +$156K 0.22% 88

Other funds holding AHPI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MYDA Advisors's AHPI Position: Q2 2020 in Review

MYDA Advisors sold out of Allied Healthcare Products (AHPI) in Q2 2020, closing a stake of 20,000 shares — an estimated $350K sold.

MYDA Advisors first reported a position in AHPI in Q1 2020 and held it in 1 quarter. The position peaked at $350K in Q1 2020. 19 funds tracked by Wall St. Rank hold AHPI as of Q2 2020.

  • MYDA Advisors reported no remaining Allied Healthcare Products position as of Q2 2020 after selling out during the quarter.
  • MYDA Advisors sold 20,000 Allied Healthcare Products shares in Q2 2020, an estimated $350K.
  • MYDA Advisors first reported a position in Allied Healthcare Products in Q1 2020 and held it in 1 quarter.
  • MYDA Advisors's Allied Healthcare Products position peaked at $350K in Q1 2020.
  • 19 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q2 2020.

Based on MYDA Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.